La Commissione Europea ha deciso di prorogare le scadenze dei seguenti bandi, causa dell’emergenza Covid-19:
- Horizon Impact Award – nuova scadenza 15 aprile 2020
- Societal challenge 3 – Secure, claena and efficvient energy – nuova scadenza 21 aprile 2020
- LC-SC3-JA-5-2020 (RIA): Long Term EU-Africa Partnership for Research and Innovation actions in the area of renewable energy
- LC-SC3-RES-10-2020 (PCP): Pre-Commercial Procurement for a 100% Renewable Energy Supply
- Societal Challenge 1 – Health – nuova scadenza 4 giugno 2020
- SC1-BHC-37-2020 (RIA-LS): Towards the new generation of clinical trials – trials methodology research
- SC1-BHC-06-2020 (RIA): Digital diagnostics – developing tools for supporting clinical decisions by integrating various diagnostic data
- SC1-BHC-11-2020 (RIA): Advancing the safety assessment of chemicals without the use of animal testing
- SC1-BHC-17-2020 (RIA): Global Alliance for Chronic Diseases (GACD) – Prevention and/or early diagnosis of cancer
- SC1-BHC-20A-2020 (PCP): Pre-commercial procurement (PCP) for integrated care solutions
- SC1-BHC-20B-2020 (PPI): Public procurement of innovative solutions (PPI) for diagnostics for infectious diseases
- SC1-BHC-33-2020 (RIA): Addressing low vaccine uptake
- SC1-BHC-34-2020 (RIA): New approaches for clinical management and prevention of resistant bacterial infections in high prevalence settings
- SC1-BHC-35-2020 (RIA): Creation of a European wide sustainable network for harmonised large-scale clinical research studies for infectious diseases
- SC1-BHC-36-2020 (RIA): Micro- and nano-plastics in our environment: Understanding exposures and impacts on human health
- SC1-DTH-12-2020 (RIA): Use of Real-World Data to advance research on the management of complex chronic conditions
- SC1-HCC-10-2020 (CSA): Towards a Health research and innovation Cloud: Capitalising on data sharing initiatives in health research
- SC1-HCO-01-2018-2019-2020 (CSA): Actions in support of the International Consortium for Personalised Medicine
- SC1-HCO-03-2020 (CSA): Bridging the divide in health research and innovation – boosting return on investment
- SC1-HCO-07-2020 (ERA-NETCofund): ERA-NET to support the Joint Programming Initiative on Antimicrobial resistance (JPIAMR)
- SC1-HCO-14-2020 (ERA-NETCofund): ERA-NET: Sustained collaboration of national and regional programmes in cancer research
- SC1-HCO-16-2020 (ERA-NETCofund): ERA-NET: Sustained collaboration of national and regional programmes in research on brain-related diseases and disorders of the nervous system
- SC1-HCO-17-2020 (CSA): Coordinating and supporting research on the human microbiome in Europe and beyond
- SC1-HCO-18-2020 (CSA): Developing methodological approaches for improved clinical investigation and evaluation of high-risk medical devices
- SC1-HCO-19-2020 (CSA): Reliable and accessible information on cell and gene-based therapies
- SC1-HCO-20-2020 (CSA): Coordination of clinical research activities of the European Reference Networks